153 related articles for article (PubMed ID: 36693779)
1. CRISPR/Cas9 and Chlorophyll Coordination Micelles for Cancer Treatment by Genome Editing and Photodynamic Therapy.
Zhang C; Wang X; Liu G; Ren H; Liu J; Jiang Z; Zhang Y
Small; 2023 Apr; 19(17):e2206981. PubMed ID: 36693779
[TBL] [Abstract][Full Text] [Related]
2. Metal coordination micelles for anti-cancer treatment by gene-editing and phototherapy.
Zhang C; Wang X; Liu G; Ren H; Li J; Jiang Z; Liu J; Lovell JF; Zhang Y
J Control Release; 2023 May; 357():210-221. PubMed ID: 36972864
[TBL] [Abstract][Full Text] [Related]
3. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects.
Deng S; Li X; Liu S; Chen J; Li M; Chew SY; Leong KW; Cheng D
Sci Adv; 2020 Jul; 6(29):eabb4005. PubMed ID: 32832641
[TBL] [Abstract][Full Text] [Related]
4. Effective Genome Editing Using CRISPR-Cas9 Nanoflowers.
Zhang C; Ren H; Liu G; Li J; Wang X; Zhang Y
Adv Healthc Mater; 2022 May; 11(10):e2102365. PubMed ID: 34989166
[TBL] [Abstract][Full Text] [Related]
5. Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy.
Pu Y; Yin H; Dong C; Xiang H; Wu W; Zhou B; Du D; Chen Y; Xu H
Adv Mater; 2021 Nov; 33(45):e2104641. PubMed ID: 34536041
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
7. Pluronic-encapsulated natural chlorophyll nanocomposites for in vivo cancer imaging and photothermal/photodynamic therapies.
Chu M; Li H; Wu Q; Wo F; Shi D
Biomaterials; 2014 Sep; 35(29):8357-73. PubMed ID: 25002262
[TBL] [Abstract][Full Text] [Related]
8. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
9. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient photodynamic therapy colloidal system based on chloroaluminum phthalocyanine/pluronic micelles.
Py-Daniel KR; Namban JS; de Andrade LR; de Souza PEN; Paterno LG; Azevedo RB; Soler MAG
Eur J Pharm Biopharm; 2016 Jun; 103():23-31. PubMed ID: 27018329
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated knockout of NYC1 gene enhances chlorophyll retention and reduces tillering in Zoysia matrella (L.) Merrill.
Ng HM; Gondo T; Tanaka H; Akashi R
Plant Cell Rep; 2024 Feb; 43(2):50. PubMed ID: 38305919
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of doxorubicin and pheophorbide A by pluronic F127 micelles for chemo-photodynamic combination therapy of melanoma.
Zhang C; Zhang J; Qin Y; Song H; Huang P; Wang W; Wang C; Li C; Wang Y; Kong D
J Mater Chem B; 2018 May; 6(20):3305-3314. PubMed ID: 32254388
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
Minkenberg B; Wheatley M; Yang Y
Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment.
Akram F; Haq IU; Sahreen S; Nasir N; Naseem W; Imitaz M; Aqeel A
Technol Cancer Res Treat; 2022; 21():15330338221132078. PubMed ID: 36254536
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy.
Aziz A; Rehman U; Sheikh A; Abourehab MAS; Kesharwani P
J Biomater Sci Polym Ed; 2023 Feb; 34(3):398-418. PubMed ID: 36083788
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Editing of the
Mirgayazova R; Khadiullina R; Chasov V; Mingaleeva R; Miftakhova R; Rizvanov A; Bulatov E
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32630614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
